The novel multi-cytokine inhibitor TO-207 specifically inhibits pro-inflammatory cytokine secretion in monocytes without affecting the killing ability of CAR T cells

Cancer immunotherapy using chimeric antigen receptor–armed T (CAR T) cells have been shown to improve outcomes significantly in patients with hematological malignancies. However, cytokine release syndrome (CRS) remains a risk. CRS is characterized by the excessive activation of CAR T cells and macro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Futami, Muneyoshi, Suzuki, Keisuke, Kato, Satomi, Ohmae, Saori, Tahara, Yoshio, Nojima, Masanori, Imai, Yoichi, Mimura, Takayuki, Watanabe, Yoshihiro, Tojo, Arinobu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2020
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7176125/
https://ncbi.nlm.nih.gov/pubmed/32320454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0231896
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak